CINRYZE 500
0624-301
Phase 3 mab completed
Quick answer
CINRYZE 500 for Hereditary Angioedema (HAE) is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hereditary Angioedema (HAE)
- Phase
- Phase 3
- Modality
- mab
- Status
- completed